Tissue | Species | CAA status | Secretion | Cancer | Experiment | Reference |
---|---|---|---|---|---|---|
Pancreas | Human | Dedifferentiation Dysregulated metabolism Delipidation |
FFA, matrix remodeling factors, angiogenic factors | Enhanced migration Desmoplasia |
Co-culture, RNA analysis, trans-well, transcriptome analysis | (Cai et al., 2019) |
Pancreas | Human | Overexpression of Wnt signaling pathway | EMT inducing factors, WNT paracrine factors | EMT induction Enhanced migration |
Wound healing assay, invasion assay, CM treatment, gene expression profile, RNA analysis | (Carbone et al., 2018) |
Pancreas | Mouse | Dedifferentiation Lipolysis Fibrosis |
FFA, HGF | Wnt5a secretion Enhanced FFA uptake Enhanced migration and invasion Chemoresistance |
Organotypic fat invasion model, CM treatment, co-culture, FACS | (Okumura et al., 2017) |
Breast | Mouse Human |
Delipidation Reduced lipid droplet size and number |
Protease, MMP11, IL-6, IL-1β, PAI1 | Enhanced invasive phenotype | Co-culture, metastasis assay | (Dirat et al., 2011) |
Breast | Mouse Human |
Fibrosis Wnt/β-catenin activation FSP overexpression |
Fibronectin, collagen I | Enhanced migration and invasion Enhanced CAF marker Enhanced FSP-1 Wnt3a secretion |
Co-culture, fat pad injection, IHC, H&E staining, migration, invasion assay, glucose uptake assessment | (Bochet et al., 2013) |
Breast | Human | IGFBP2 overexpression Delipidation |
FFA, IGFBP2, ANGPTL4, IL6sR, IL8, insulin, leptin, MIF, PDGF, TGF-β, TNF-α | Enhanced MMP2 Decreased E-cadherin Enhanced metastasis |
Co-culture, CM treatment, adipokine array, migration, invasion assay | (Wang et al., 2015) |
Ovary | Mouse Human |
Lipolysis Homing and lipid supply to tumor |
FFA, IL-6, IL-8, MCP1, TIMP-1, adiponectin | Enhanced homing, migration, and invasion Overexpressed FABP4 Cytoplasmic lipid droplet accumulation |
Co-culture, protein array, H&E staining, xenograft | (Nieman et al., 2011) |
Ovary | Mouse Human |
Lipid supply to tumor | IL8, IL6, FFA, leptin, adiponectin, prostaglandin, lipoxin, arachidonic acid | Enhanced chemoresistance Reduced cleaved PARP PI3K/Akt activation STAT3 activation |
CM treatment, FACS, lipidomic analysis, lipid extraction, protein fractionation | (Yang et al., 2019) |
Ovary | Human | Downregulation of Acetyl-CoA carboxylase | FFA, IL8 | Enhanced metastasis Enhanced FFA uptake CD36 overexpression AMPK activation |
Co-culture, CD36 inhibition, xenograft, H&E staining, TUNEL assay | (Ladanyi et al., 2018) |
Prostate | Mouse Human |
CCL7 and leptin overexpression Extraprostatic extension |
CCL7, CXCR2, CXCR4, CXCL12, IL6, MMPs | Enhanced migration Enhanced invasion CCR3 (master regulator) CCR4 |
CM treatment, IHC, proteomic analysis, orthotopic transplantation, FACS, Mass spec | (Laurent et al., 2016) |
Colon | Mouse | Lipolysis Support cancer cell growth and survival | FFA, glycerol | Upregulated mitochondrial fatty acid oxidation Enhanced oxygen consumption AMPK/autophagy activation Dedifferentiation |
Co-culture, 3D organoids culture, xenograft, IHC, OCR assay, autophagy flux assay | (Wen et al., 2017) |
CAA, cancer-associated adipocytes; FFA, free fatty acid; EMT, epithelial-mesenchymal transition; CM, conditioned media; HGF, hepatocyte growth factor; FACS, fluorescence-activated cell sorting; MMP, metalloproteinase; IL, interleukin; PAI1, plasminogen activator inhibitor 1; CAF, cancer-associated fibroblast; FSP-1, fibroblast-specific protein-1; IHC, immunohistochemistry; IGFBP2, insulin growth factor-binding protein 2; ANGPTL4, angiopoietin-like 4; MIF, macrophage migration inhibitory factor; PDGF, platelet-derived growth factor receptor; TGF-β, transforming growth factor-beta; TNF-α, tumor necrosis factor-α; MCP-1, monocyte chemoattractant protein-1; TIMP-1, tissue inhibitor of metalloproteinase 1; FABP4, fatty acid-binding protein 4; PARP, poly (ADP-ribose) polymerase; PI3K, phosphoinositide 3-kinase; Akt, protein kinase 8; STAT3, signaling transducer and activator of transcription 3; AMPK, AMP-activated protein kinase; CCL7, chemokine (C-C motif) ligand; CXCR, C-X-C motif chemokine receptor; CXCL, C-X-C motif chemokine ligand; CCR, C-C chemokine receptor; OCR, oxygen consumption rate.